Adapting Market-By-Market

Global pharma strategy starts with anchoring on a product’s universal truth — how it works, its risks, and its benefits — before adapting to the realities of each local market. Those local plans must account for regulatory requirements, competitive dynamics, trial populations, insurance landscapes, and whether patients can realistically access and afford treatment.

Operationally, the work is about translating long-term goals into concrete near-term priorities — weekly and quarterly milestones that keep teams moving in the right direction. When new data or market information emerges, plans should be adjusted thoughtfully rather than reactively, with clear rationale communicated so everyone stays aligned through the change.